1Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges[J]. Nat Rev Drug Discov, 2010,9(10) :775-789.
2Lopez-Casas PP, Lopez-Ferndndez LA. Gene-expression profi- ling in pancreatic cancer [J]. Expert Rev Mol Diagn, 2010,10 (5) :591-601.
3Rachagani S, Kumar S, Batra SK. MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications[J]. Cancer Lett, 2010,292(1) :8-16.
4Kent OA, Mullendore M, Wentzel EA, et al. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcino- ma cells[J].Cancer Biol Ther, 2009,8(11):2013-2024.
5Garrido-Laguna I, Tan AC, Uson M, et aI. Integrated preclini- cal and clinical development of roTOR inhibitors in pancreatic cancer [J].Br J Cancer, 2010,103(5) :649-655.
6Dihra HK, Brown JE, Hooley P, et al. Aspirin and alterations in DNA repair proteins in the SW480 colorectal cancer cell line[J].OncnlRep, 2010, 24(1):37-46.
